MP
IART icon

Mangrove Partners’s Integra LifeSciences IART Stock Holding History

Mangrove Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$769K Buy
+42,830
New +$599K 0.05% 150

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Mangrove Partners's IART Position: Q2 2026 in Review

Mangrove Partners opened a new position in Integra LifeSciences (IART) in Q2 2026: 42,830 shares worth $769K. The stake represents 0.05% of the portfolio and ranks #150 among its holdings.

212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Mangrove Partners held 42,830 shares of Integra LifeSciences worth $769K as of Q2 2026.
  • Integra LifeSciences was a new Mangrove Partners position in Q2 2026.
  • Integra LifeSciences made up 0.05% of Mangrove Partners's portfolio in Q2 2026, its #150 holding.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.